Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT03079323
PHASE2
Trial to Investigate the Benefit of Elective Para-Aortic Radiotherapy (PART) for pN1 Prostate Cancer
Sponsor: Universitaire Ziekenhuizen KU Leuven
View on ClinicalTrials.gov
Summary
Prospective non-randomized phase 2 trial to study the efficacy of additional elective para-aortic RT (PART) in pN1 patients compared to those who were historically treated with adjuvant whole pelvic radiotherapy (WPRT) alone.
Official title: Phase II Trial to Investigate the Benefit of Elective Para-Aortic Radiotherapy (PART) for pN1 Prostate Cancer Using Arc Therapy (IMAT/VMAT)
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
137
Start Date
2017-02-06
Completion Date
2025-02-01
Last Updated
2024-07-03
Healthy Volunteers
No
Conditions
Interventions
RADIATION
PART-trial
Elective radiation to the para-aortic lymph nodes 45 Gy / 1.8 Gy
Locations (1)
UZ Leuven
Leuven, Belgium